ESR1 and breast cancer: Gallen consensus [14,23], breast cancer subtypes such as luminal A or B, HER2-positive, and triple-negative are classified based on the positivity of ER or PgR expression, HER2 overexpression, and Ki-67 expression related to cell proliferation.